Patent · US Active

Crystalline anti-human IL-12 antibodies

US8168760B2 · kind B2 · utility

12Cited by
38References
45Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 27, 2008
Grant dateMay 1, 2012
Priority date
Expiry dateNov 14, 2028

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to batch crystallization methods for crystallizing an anti-hIL-12 antibody that allows the production of the antibody on an industrial scale, antibody crystals obtained according to the methods, compositions containing the crystals, and methods of using the crystals and the compositions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.